PortfoliosLab logoPortfoliosLab logo
HCAT vs. AVAH
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

HCAT vs. AVAH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Health Catalyst, Inc. (HCAT) and Aveanna Healthcare Holdings Inc. (AVAH). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, HCAT achieves a -12.55% return, which is significantly lower than AVAH's 14.93% return.


HCAT

1D
0.48%
1M
0.48%
6M
-2.79%
YTD
-12.55%
1Y
-40.63%
3Y*
-47.35%
5Y*
-48.57%
10Y*
ALL TIME*
-33.73%

AVAH

1D
-3.10%
1M
3.19%
6M
11.79%
YTD
14.93%
1Y
151.07%
3Y*
77.47%
5Y*
-1.91%
10Y*
ALL TIME*
-4.56%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$17.44M$20.18M$16.91M
$1.03M$1.46M$2.83M

HCAT vs. AVAH - Yearly Performance Comparison


2026 (YTD)20252024202320222021
HCAT
Health Catalyst, Inc.
-12.55%-66.20%-23.65%-12.89%-73.17%-29.78%
AVAH
Aveanna Healthcare Holdings Inc.
14.93%78.77%70.52%243.59%-89.46%-38.33%

Correlation

The correlation between HCAT and AVAH is 0.24, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.24

Correlation (3Y)
Balances recent behavior with more history.

0.30

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.29

Correlation (All Time)
Calculated using the full available price history since Apr 28, 2021

0.29

Fundamentals

Market Cap

HCAT:

$154.44M

AVAH:

$2.04B

EPS

HCAT:

-$3.72

AVAH:

$1.19

PS Ratio

HCAT:

0.49

AVAH:

0.82

PB Ratio

HCAT:

1.10

AVAH:

8.69

Total Revenue (TTM)

HCAT:

$302.48M

AVAH:

$2.52B

Gross Profit (TTM)

HCAT:

$103.36M

AVAH:

$823.98M

EBITDA (TTM)

HCAT:

-$85.17M

AVAH:

$306.37M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HCAT vs. AVAH — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

HCAT
HCAT Risk / Return Rank: 2525
Overall Rank
HCAT Sharpe Ratio Rank: 2323
Sharpe Ratio Rank
HCAT Sortino Ratio Rank: 2626
Sortino Ratio Rank
HCAT Omega Ratio Rank: 2727
Omega Ratio Rank
HCAT Calmar Ratio Rank: 2323
Calmar Ratio Rank
HCAT Martin Ratio Rank: 2424
Martin Ratio Rank

AVAH
AVAH Risk / Return Rank: 9191
Overall Rank
AVAH Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
AVAH Sortino Ratio Rank: 9696
Sortino Ratio Rank
AVAH Omega Ratio Rank: 9494
Omega Ratio Rank
AVAH Calmar Ratio Rank: 9090
Calmar Ratio Rank
AVAH Martin Ratio Rank: 8383
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

HCAT vs. AVAH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Health Catalyst, Inc. (HCAT) and Aveanna Healthcare Holdings Inc. (AVAH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


HCATAVAHDifference
Sharpe ratioReturn per unit of total volatility

-2.52

Sortino ratioReturn per unit of downside risk

-3.83

Omega ratioGain probability vs. loss probability

0.97

1.43

-0.47

Calmar ratioReturn relative to maximum drawdown

-0.58

3.48

-4.06

Martin ratioReturn relative to average drawdown

-0.94

6.42

-7.37

HCAT vs. AVAH - Sharpe Ratio Comparison

The current HCAT Sharpe Ratio is -0.47, which is lower than the AVAH Sharpe Ratio of 2.05. The chart below compares the historical Sharpe Ratios of HCAT and AVAH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

HCAT vs. AVAH - Drawdown Comparison

The maximum HCAT drawdown since its inception was -98.30%, roughly equal to the maximum AVAH drawdown of -94.76%. Use the drawdown chart below to compare losses from any high point for HCAT and AVAH.


Loading charts...

Drawdown Indicators


HCATAVAHDifference

Max Drawdown

Largest peak-to-trough decline

-98.30%

-94.76%

-3.54%

Max Drawdown (1Y)

Largest decline over 1 year

-73.92%

-39.44%

-34.48%

Max Drawdown (3Y)

Largest decline over 3 years

-92.79%

-40.76%

-52.03%

Max Drawdown (5Y)

Largest decline over 5 years

-98.27%

-93.24%

-5.03%

Current Drawdown

Current decline from peak

-96.44%

-27.15%

-69.29%

Average Drawdown

Average peak-to-trough decline

-63.19%

-62.72%

-0.47%

Ulcer Index

Depth and duration of drawdowns from previous peaks

45.43%

21.34%

+24.09%

Volatility

HCAT vs. AVAH - Volatility Comparison

Health Catalyst, Inc. (HCAT) has a higher volatility of 14.28% compared to Aveanna Healthcare Holdings Inc. (AVAH) at 11.77%. This indicates that HCAT's price experiences larger fluctuations and is considered to be riskier than AVAH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HCATAVAHDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.28%

11.77%

+2.51%

Volatility (6M)

Calculated over the trailing 6-month period

72.29%

30.45%

+41.84%

Volatility (1Y)

Calculated over the trailing 1-year period

91.08%

66.96%

+24.12%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

71.84%

78.32%

-6.48%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

67.76%

76.71%

-8.95%

Dividends

HCAT vs. AVAH - Dividend Comparison

Neither HCAT nor AVAH has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

HCAT vs. AVAH - Financials Comparison

This section allows you to compare key financial metrics between Health Catalyst, Inc. and Aveanna Healthcare Holdings Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


HCAT and AVAH have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

HCAT has higher volatility (14.28%) compared to AVAH (11.77%). In terms of maximum drawdown, HCAT dropped -98.30% vs AVAH's -94.76%.

AVAH currently has the higher Sharpe Ratio (2.05 vs -0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HCAT and AVAH

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer